# FDA Inspection 1121216 - CorneaGen - Boston - March 05, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/corneagen-boston/7a831ad9-4224-4fc8-8e7e-d1a6abb53f03
Source feed: FDA_Inspections

> FDA Inspection 1121216 for CorneaGen - Boston on March 05, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121216
- Company Name: CorneaGen - Boston
- Inspection Date: 2020-03-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1257221 - 2024-12-20](https://www.globalkeysolutions.net/records/fda_inspections/corneagen-boston/43ca6f6d-9fc0-4574-8a2c-ae5be00b98c8)
- [FDA Inspection 1121216 - 2020-03-05](https://www.globalkeysolutions.net/records/fda_inspections/corneagen-boston/5eec9d36-3c8d-44a5-aa7e-c1847cb300ff)
- [FDA Inspection 1121216 - 2020-03-05](https://www.globalkeysolutions.net/records/fda_inspections/corneagen-boston/f1850371-f861-48c2-b3ae-2c4022fa55f5)
- [FDA Inspection 1068364 - 2018-09-12](https://www.globalkeysolutions.net/records/fda_inspections/corneagen-boston/172a0e4b-9bf1-44dc-833e-a9c9f79b973c)
- [FDA Inspection 941531 - 2015-08-20](https://www.globalkeysolutions.net/records/fda_inspections/corneagen-boston/426b84fd-7341-4f22-9b96-ca08363fba0c)

Company: https://www.globalkeysolutions.net/companies/corneagen-boston/78964c02-d403-4377-8609-2434e1adaef8

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d